Study Group: Velcade Prescribers for Multiple Myeloma: Oncologists (US)(?)
Council Members in this Study Group: 21
Request a survey with this Study Group
Leading Experts in this Study Group
Instructor in Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Eric Jacobsen, MD, is a Medical Oncologist and Hematologist in the Hematology/Oncology Department at Dana Farber Cancer Institute in Boston, Massachusetts. His clinical focus is on lymphoma and is very involved in Phase II/III clinical trials for new compounds as well as stem cell transplantation.
Haitham Al-Okk, MDAssistant Clinical Professor - Hematology-Oncology
Mahr Cancer Center
Haitham Al-Okk, MD, is a Specialist in Hematology-Oncology at Graves-Gilbert Cancer Clinic, a multi-specialty medical group in Kentucky. Dr. Al-Okk is board certified in Internal Medicine and Medical Oncology, and fellowship trained in Hematology-Oncology. He specializes in lung, breast, and colorectal...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
I participated in a number of the trials described in the article. High dose cyclophosphamide certainally works well in a number of autoimmune diseases, but it is unclear how the use of this old drug will be protected by the company, who actually is going to be willing to administer the treatment...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Biotechnology Manufacturer
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Director
- Physician - Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms